NFSCF (Enphys Acquisition) Research & Development : $0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Enphys Acquisition Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Enphys Acquisition's Research & Development for the three months ended in Jun. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.

Enphys Acquisition Research & Development Historical Data

The historical data trend for Enphys Acquisition's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enphys Acquisition Research & Development Chart

Enphys Acquisition Annual Data

Trend

Dec21

Dec22

Dec23

Research & Development

Enphys Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Research & Development	Get a 7-Day Free Trial									-	-	-	-	-

Enphys Acquisition Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Enphys Acquisition (OTCPK:NFSCF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Enphys Acquisition Research & Development Related Terms

Thank you for viewing the detailed overview of Enphys Acquisition's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Enphys Acquisition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Enphys Acquisition Corp (OTCPK:NFSCF) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Wall Street, 20th Floor, New York, NY, USA, 10005

Website

https://www.enphyspac.com

Enphys Acquisition Corp is a blank check company.

Executives

Carlos N. Guimaraes	other: Director Nominee	555 MADISON AVENUE, SUITE 11A, NEW YORK NY 10022
Helio L. Magalhaes	other: Director Nominee	10 E 53RD ST., NEW YORK NY 10022
Pablo Jorge De	director, 10 percent owner, officer: Chief Executive Officer	56 BELL STREET, MARYLEBONE, LONDON X0 NW1 5DA
Bueno Jose Antonio Aguilar	other: Director Nominee	PASEO DE LOS TAMARINDOS 400 B SUITE 101, COL. BOSQUES DE LAS LOMAS, MEXICO CITY O5 CDMX 05120
Bujan Matias De	officer: Chief Operating Officer	AV. GELLY Y OBES 2207, 2DO PISO, BUENOS AIRES C1 1425
Federico Carrillo-zurcher	other: Director Nominee	PLAZA ARAGON 2, PLISO 9A, ZARAGOZA U3 50004
Par Arne Lindstrom	director, officer: Chief Financal Officer	1149 3RD STREET, SUITE 300, SANTA MONICA CA 90403
Enphys Acquisition Sponsor Llc	10 percent owner	216 EAST 45TH STREET, 13TH FLOOR, NEW YORK NY 10017
Eva Redhe	other: Director Nominee	GUMSHORNSGATAN 7, STOCKHOLM V7 11460

Enphys Acquisition Headlines

No Headlines